Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Diabetes Mellitus × 1 year × Clear all

Phase

Phase NA 18 Phase EARLY_PHASE1 3 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 31 Carcinoma, Non-Small-Cell Lung 24 Neoplasm Metastasis 18 Breast Neoplasms 17 Prostatic Neoplasms 16 Colorectal Neoplasms 15 Carcinoma, Hepatocellular 12 Stomach Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Lung Neoplasms 10 Recurrence 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Ovarian Neoplasms 9 Leukemia, Myeloid, Acute 9 Pancreatic Neoplasms 8 Myasthenia Gravis 8 Melanoma 8 Leukemia 7 Urinary Bladder Neoplasms 6 Rectal Neoplasms 6 Lymphoma 6 Hematologic Neoplasms 6 Glioblastoma 6 Fatigue 6 Endometrial Neoplasms 6 Cholangiocarcinoma 6 Multiple Myeloma 5 Mouth Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Laryngeal Neoplasms 5

Interventions

saxagliptin 1 dapagliflozin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡